Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1966 2
1968 1
1970 1
1976 1
1977 1
1978 1
1986 1
1987 2
1989 1
1990 3
1991 2
1993 2
1994 4
1995 3
1996 4
1997 9
1998 2
1999 4
2000 9
2001 8
2002 10
2003 7
2004 19
2005 17
2006 23
2007 29
2008 39
2009 41
2010 40
2011 50
2012 52
2013 58
2014 80
2015 85
2016 74
2017 77
2018 96
2019 99
2020 112
2021 127
2022 132
2023 119
2024 137
2025 139

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,535 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab in Membranous Nephropathy.
Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, van den Hoogen MWF, Hrušková Z, Jeyabalan A, Karras A, King C, Kohli HS, Mayer G, Maas R, Muto M, Moiseev S, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Schönermarck U, Segelmark M, Smith L, Tesař V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A; RITERM study group. Gauckler P, et al. Among authors: ramachandran r. Kidney Int Rep. 2021 Jan 13;6(4):881-893. doi: 10.1016/j.ekir.2020.12.035. eCollection 2021 Apr. Kidney Int Rep. 2021. PMID: 33912740 Free PMC article. Review.
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.
Gauckler P, Matyjek A, Kapsia S, Marinaki S, Quintana LF, Diaz MM, King C, Griffin S, Ramachandran R, Odler B, Eller K, Artan AS, Mirioglu S, Busch M, Schaepe M, Turkmen K, Cheung CK, Pepper RJ, Juarez GF, Pascual J, Auñón P, García-Carro C, Rodriguez A, Alberici F, Luzardo L, Chebotareva N, Schönermarck U, Fernández L, Radhakrishnan J, Guaman K, Peleg Y, Hoisnard L, Audard V, Papasotiriou M, Krnanska N, Tesar V, Hruskova Z, Bruchfeld A, Stangou M, Lioulios G, Faguer S, Ribes D, Salhi S, Windpessl M, Galešić K, Crnogorac M, Zagorec N, Mayer G, Kronbichler A; RITERM Study Team. Gauckler P, et al. Among authors: ramachandran r. J Am Soc Nephrol. 2025 Apr 1;36(4):668-678. doi: 10.1681/ASN.0000000520. Epub 2024 Oct 16. J Am Soc Nephrol. 2025. PMID: 39431468
Acrodermatitis acidaemica.
Maguire CA, Chong H, Ramachandran R, Popoola J, Akhras V, Singh M. Maguire CA, et al. Among authors: ramachandran r. Clin Exp Dermatol. 2018 Apr;43(3):315-318. doi: 10.1111/ced.13369. Epub 2018 Jan 15. Clin Exp Dermatol. 2018. PMID: 29336047
Hypertriglyceridaemia: an update.
Wierzbicki AS, Kim EJ, Esan O, Ramachandran R. Wierzbicki AS, et al. Among authors: ramachandran r. J Clin Pathol. 2022 Dec;75(12):798-806. doi: 10.1136/jclinpath-2021-207719. Epub 2022 Jun 16. J Clin Pathol. 2022. PMID: 35710321 Review.
Ocular manifestations in IgA nephropathy.
Oo HH, Choy MYD, Arora A, Yeo SC, Ramachandran R, Gupta V, McCluskey P, Agrawal R. Oo HH, et al. Among authors: ramachandran r. Surv Ophthalmol. 2023 Mar-Apr;68(2):290-307. doi: 10.1016/j.survophthal.2022.09.004. Epub 2022 Oct 1. Surv Ophthalmol. 2023. PMID: 36191648 Review.
How Do We Pay for Glaucoma Screening?
Ramachandran R, Ehrlich JR, Stein JD. Ramachandran R, et al. J Glaucoma. 2024 Aug 1;33(Suppl 1):S67-S70. doi: 10.1097/IJG.0000000000002416. Epub 2024 Aug 19. J Glaucoma. 2024. PMID: 39149953 No abstract available.
1,535 results